Back

Anticoagulation in atrial fibrillation - Current landscape

1 September 2019 (18:20 - 18:35)
Organised by:
Congress Presentation Part of: Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation Stroke Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail
Welcome and objectives
Professor G. Montalescot (Paris, FR)
Slides Video
Presentation thumbnail
Establishing NOACs as standard of care in clinical practice
Professor G. Lip (Liverpool, GB)
Slides Video
Presentation thumbnail
Exploring outstanding unmet needs in atrial fibrillation patients with acute coronary syndrome and/or undergoing percutaneous coronary intervention
Professor R. Lopes (Durham, US)
Slides Video
Presentation thumbnail
Advancing patient care with NOACs in other cardiac interventions
Professor G. Montalescot (Paris, FR)
Slides Video
Presentation thumbnail
Improving outcomes through atrial fibrillation screening - Future directions
Professor R. Schnabel (Hamburg, DE)
Slides Video

Access the full session

Session thumbnail
Non-vitamin K antagonist oral anticoagulants (NOACs): from new evidence to improved patient outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2019

1 September 2019 18:20 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources